Both in Pharmaceuticals
Bicara Therapeutics vs Nuvectis Pharma
Over the past year BCAX returned −45.1% and NVCT returned +171.4%; their daily moves had a correlation of 0.15.
BCAX −45.1% NVCT +171.4%Growth of $1, one year, split-adjusted
| Metric | BCAX | NVCT |
|---|---|---|
| Price | $8.96 | $19.34 |
| Market cap | $592.9M | $631.3M |
| Today | +12.99% | +0.83% |
| 1 month | −48.2% | −9.6% |
| 6 months | −61.3% | +99.2% |
| Year to date | −46.8% | +156.2% |
| 1 year | −44.9% | +188.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $497.3M | $22.2M |
| Dividend yield | — | — |
| Volatility (60d) | 134.8% | 68.0% |
| Short % of float | 23.9% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).